ANNX
Annexon Inc

1,013
Loading...
Loading...
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
100

Frequently Asked Questions

What is Market Cap of Annexon Inc?
What is the 52-week high for Annexon Inc?
What is the 52-week low for Annexon Inc?
What is Annexon Inc stock price today?
What was Annexon Inc stock price yesterday?
What is the PE ratio of Annexon Inc?
What is the Price-to-Book ratio of Annexon Inc?
What is the 50-day moving average of Annexon Inc?
How many employess does Annexon Inc has?

Latest ANNX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.